Analysis on the effect of transvaginal ultrasound intervention combined with MTX and mifepristone on the treatment of the patients with scar pregnancy after cesarean section
Objective To investigate and analyze the clinical effect of transvaginal ultrasound intervention combined with MTX and mifepristone on the treatment of the patients with scar pregnancy after cesarean section. Methods 40 patients with scar pregnancy after cesarean section were selected as the object of study in Lishui people's hospital from May 2016 to June 2017. The control group was treated with conventional MTX and mifepristone, intramuscular injection of 50 mg/m2 methotrexate, mifepristone orally, two times a day. The experimental group was injected with MTX under the guidance of transvaginal ultrasound. The patients were given oral mifepristone, and curettage or uterine artery plug was performed according to the actual situation. The hospitalization time, cure rate, vaginal blood loss in the experimental group and the control group were compared and analyzed. Results The hospitalization time in the experimental group was (9.34±3.53) d, while in the control group was (22.43±5.90) d, the difference in the two groups had statistically significant (P<0.05). The vaginal bleeding volume in the experimental group was (33.87±6.54) mL, which was significantly longer than (173.20±10.89) mL in the experimental group (P<0.05). The success rate in the control group was 80% (16/20), which was significantly lower than that in the experimental group 100%(20/20) (P<0.05). Conclusion The clinical effect is ideal which transvaginal ultrasound intervention combined with MTX and mifepristone were used on the treatment of cesarean scar pregnancy, it can significantly improve clinical symptoms, has high safety.
NETL
NSTL
万方数据
维普
